GlaxoSmithKline has become the latest pharmaceuticals company to be accused of paying bribes to win business in China. In the past year, Eli Lilly and Pfizer have reached settlements with US authorities over similar allegations concerning their conduct in China.
葛蘭素史克（GlaxoSmithKline，簡稱GSK）成為最新一家被控靠行賄在中國市場贏取業務的制藥公司。去年，禮來(Eli Lilly)和輝瑞(Pfizer)已就關于其在中國行為的類似指控，與美國監管當局達成了和解。
您已閱讀12%（372字），剩余88%（2828字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。